You just read:

CSA Medical, Inc. Receives FDA Breakthrough Device Designation and IDE Approval for its RejuvenAir® System for COPD Patients with Chronic Bronchitis

News provided by

CSA Medical Inc.

Apr 03, 2019, 08:50 ET